tiprankstipranks
Trending News
More News >
Shanghai Conant Optical Co. Ltd. Class H (HK:2276)
:2276
Hong Kong Market

Shanghai Conant Optical Co. Ltd. Class H (2276) AI Stock Analysis

Compare
1 Followers

Top Page

HK:2276

Shanghai Conant Optical Co. Ltd. Class H

(2276)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
HK$69.00
▲(27.54% Upside)
Action:ReiteratedDate:01/15/26
Score is driven primarily by strong financial performance (growth, profitability, low leverage, and high-quality operating cash flow) and supported by bullish technical positioning (above key moving averages with positive MACD). The main constraint is valuation, with a high P/E and limited dividend yield.
Positive Factors
Revenue Growth
Consistent mid-teens revenue growth and multi-year increases indicate durable demand and successful commercial execution. Sustained top-line expansion supports scale benefits, funds R&D and distribution investments, and underpins margin sustainability over the next several quarters to years.
High-quality Operating Cash Flow
Operating cash flow reliably exceeding net income signals high-quality earnings and strong cash conversion. That provides durable funding for capex, working capital, and shareholder returns without reliance on new debt, enhancing financial resilience and strategic optionality.
Strong Balance Sheet
Low leverage and a favorable equity mix give the company financial flexibility to invest, weather downturns, or pursue M&A. An improving ROE implies better capital efficiency, supporting sustainable profitability and lower refinancing risk over multiple business cycles.
Negative Factors
Free Cash Flow Weakness
A drop in free cash flow growth, despite strong operating cash, suggests rising capex or working capital demands that constrain distributable cash. If persistent, this limits capacity for dividends, buybacks, or debt reduction and can pressure strategic investments over months to years.
Limited Dividend Payout
A low dividend payout rate signals restrained direct returns to shareholders and may reflect management prioritizing reinvestment or balance sheet conservatism. For income-oriented investors this reduces appeal and highlights reliance on operational growth for shareholder value creation.
End-market Concentration
Concentration in consumer electronics and health exposes revenue to sector-specific cycles, technology shifts, and regulatory changes. Structural disruptions or muted demand in either end market could materially affect sales and margins over medium-term horizons.

Shanghai Conant Optical Co. Ltd. Class H (2276) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Conant Optical Co. Ltd. Class H Business Overview & Revenue Model

Company DescriptionShanghai Conant Optical Co., Ltd. engages in the manufacture and sale of resin spectacle lenses in China, Asia, the United States, Europe, the Americas, Africa, and Oceania. The company offers standardized and customized lenses. It serves spectacle lens brand owners and ophthalmic optic companies. The company was incorporated in 2011 and is headquartered in Shanghai, China.
How the Company Makes MoneyShanghai Conant Optical Co. Ltd. generates revenue through multiple streams, primarily from the sale of optical lenses and eyewear products. The company earns income from both direct retail sales and bulk orders to distributors and retailers. Key revenue streams include custom lens manufacturing, which allows for personalized solutions that cater to specific customer needs, contributing significantly to profit margins. Additionally, partnerships with health professionals and optical retailers enhance market reach and drive sales. The company also benefits from technological advancements in lens production, allowing for cost-effective manufacturing processes that improve profitability.

Shanghai Conant Optical Co. Ltd. Class H Financial Statement Overview

Summary
Strong overall fundamentals: solid revenue and profit growth with healthy EBIT/EBITDA margins (income statement strength), a stable balance sheet with low leverage and improving ROE, and operating cash flow consistently exceeding net income. Main offset is softer free cash flow growth.
Income Statement
85
Very Positive
The company has demonstrated strong growth in revenue, with a consistent increase over the past five years. The gross profit margin has been stable, reflecting effective cost management. The net profit margin has also improved, indicating enhanced profitability. The EBIT and EBITDA margins are healthy, showcasing operational efficiency. Overall, the company exhibits robust revenue and profit growth.
Balance Sheet
80
Positive
The balance sheet reveals a solid equity position with a favorable equity ratio. The debt-to-equity ratio is low, indicating prudent financial leverage. The return on equity has shown improvement, aligning with increased profitability. The company’s assets are well utilized, contributing to financial stability.
Cash Flow
78
Positive
The cash flow statement reflects a strong operating cash flow, which consistently exceeds net income, indicating high-quality earnings. However, there is a decline in free cash flow growth, requiring attention. The company maintains a healthy free cash flow to net income ratio, supporting financial flexibility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.17B2.06B1.76B1.56B1.36B1.09B
Gross Profit857.03M795.10M658.13M537.87M460.16M382.05M
EBITDA650.83M582.02M465.77M354.97M296.89M248.04M
Net Income492.42M428.28M327.02M248.57M183.52M128.46M
Balance Sheet
Total Assets3.25B2.39B1.98B1.79B1.81B1.44B
Cash, Cash Equivalents and Short-Term Investments1.32B648.52M551.52M452.14M735.34M201.85M
Total Debt232.15M317.54M214.95M355.08M599.23M675.60M
Total Liabilities734.95M803.23M589.41M643.02M873.95M939.67M
Stockholders Equity2.52B1.59B1.39B1.15B937.40M504.53M
Cash Flow
Free Cash Flow188.22M252.62M348.50M65.59M20.52M192.17M
Operating Cash Flow443.03M477.81M480.68M185.12M58.28M243.09M
Investing Cash Flow-721.19M-152.13M-273.24M-158.76M140.44M4.70M
Financing Cash Flow522.63M-157.07M-212.35M-281.00M189.27M-108.05M

Shanghai Conant Optical Co. Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price54.10
Price Trends
50DMA
58.58
Negative
100DMA
52.68
Positive
200DMA
46.23
Positive
Market Momentum
MACD
0.31
Positive
RSI
41.48
Neutral
STOCH
15.65
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2276, the sentiment is Neutral. The current price of 54.1 is below the 20-day moving average (MA) of 61.73, below the 50-day MA of 58.58, and above the 200-day MA of 46.23, indicating a neutral trend. The MACD of 0.31 indicates Positive momentum. The RSI at 41.48 is Neutral, neither overbought nor oversold. The STOCH value of 15.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2276.

Shanghai Conant Optical Co. Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$5.23B3.5117.42%3.65%6.87%18.37%
72
Outperform
HK$29.40B14.5724.57%0.63%13.58%24.59%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
42
Neutral
HK$50.63M1.0140.65%198.46%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
57.60
26.97
88.05%
HK:0907
Elegance Optical International Holdings Limited
0.06
-0.04
-43.56%
HK:3600
Modern Dental Group Limited
5.73
1.98
52.88%
HK:1942
MOG Holdings Limited
0.24
-0.61
-71.53%

Shanghai Conant Optical Co. Ltd. Class H Corporate Events

Shanghai Conant Optical Raises HK$1.4 Billion Through H-Share Placing
Feb 3, 2026

Shanghai Conant Optical Co., Ltd. has completed a share placing under its general mandate, issuing 27,000,000 new H-shares at HK$52.00 per share on 3 February 2026 to professional, institutional and other independent investors. The placing shares represent about 5.33% of the company’s enlarged share capital and generated gross proceeds of HK$1,404 million, with net proceeds of approximately HK$1,399.7 million at a net issue price of about HK$51.84 per share; no placee became a substantial shareholder, indicating that the fundraising broadens the shareholder base while preserving the existing control structure and bolstering the company’s capital position for future operational and strategic needs.

The most recent analyst rating on (HK:2276) stock is a Hold with a HK$68.00 price target. To see the full list of analyst forecasts on Shanghai Conant Optical Co. Ltd. Class H stock, see the HK:2276 Stock Forecast page.

Shanghai Conant Optical to Raise HK$1.4 Billion via Discounted Share Placement
Jan 26, 2026

Shanghai Conant Optical Co., Ltd., a PRC-incorporated optical company listed in Hong Kong, has launched a substantial share placement to institutional investors under its general mandate. The company has conditionally agreed to place 27,000,000 new H-shares at HK$52.00 per share through placing agents to at least six independent placees, representing approximately 5.63% of its existing issued share capital and about 5.33% of its enlarged share capital. The placing price reflects discounts of around 11.1% to the previous closing price and 14.38% and 7.80% to the five-day and twenty-day average closing prices respectively, positioning the deal as a discounted fundraising aimed at swift execution. Assuming full placement, the transaction is expected to raise gross proceeds of HK$1.404 billion and net proceeds of about HK$1.40 billion, modestly diluting existing shareholders while strengthening the company’s capital base, subject to final listing approval by the Stock Exchange’s Listing Committee.

The most recent analyst rating on (HK:2276) stock is a Hold with a HK$66.00 price target. To see the full list of analyst forecasts on Shanghai Conant Optical Co. Ltd. Class H stock, see the HK:2276 Stock Forecast page.

Shanghai Conant Optical Forms Smart-Glasses Lens Joint Venture With Goertek Optical
Jan 19, 2026

Shanghai Conant Optical Co., Ltd., through its wholly owned subsidiary Asahi Lite, is expanding its presence in advanced eyewear technologies, concentrating on prescription lenses and optoelectronic components tailored for smart glasses and immersive-reality devices. The company has entered into a joint venture agreement with Goertek Optical to establish a new entity focused on R&D, production and sales of prescription lenses for smart glasses, waveguide eyepieces (with and without myopia correction), and electrochromic and eye-tracking optoelectronic eyepiece components for AI/AR/VR/MR glasses, with an initial registered capital of US$1 million, 30% funded by Asahi Lite and 70% by Goertek Optical. As Goertek Inc. is a substantial shareholder of Shanghai Conant Optical, the deal is classified as a connected transaction under Hong Kong listing rules, triggering reporting and announcement requirements but exempting the company from circular and independent shareholders’ approval, signaling a strategically important yet relatively small-scale step to deepen its role in next-generation smart eyewear alongside a key shareholder-partner.

The most recent analyst rating on (HK:2276) stock is a Hold with a HK$66.00 price target. To see the full list of analyst forecasts on Shanghai Conant Optical Co. Ltd. Class H stock, see the HK:2276 Stock Forecast page.

Shanghai Conant Optical Flags At Least 30% Profit Growth for 2025
Jan 16, 2026

Shanghai Conant Optical Co. has issued a positive profit alert, stating that it expects net profit attributable to shareholders for the year ended 31 December 2025 to rise by at least 30% compared with 2024, based on preliminary unaudited management accounts. The company attributes the anticipated earnings growth to strong sales of its 1.74 refractive index lenses and other multifunctional products, improved economies of scale and higher automation levels, and efforts to optimize its financing structure and lower financing costs, although the figures remain subject to audit and possible adjustment, with full annual results due by end-March 2026 and a cautionary note to investors regarding trading in its shares.

The most recent analyst rating on (HK:2276) stock is a Hold with a HK$62.00 price target. To see the full list of analyst forecasts on Shanghai Conant Optical Co. Ltd. Class H stock, see the HK:2276 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 15, 2026